Serina Therapeutics (SER) Stock Analysis: AI Score & Alternative Data
Serina Therapeutics — alt-data steady across 90 days
Is Serina Therapeutics a buy right now? The alternative data says hold. This SER stock analysis is built on the 25+ alternative data signals AltIndex tracks on Serina Therapeutics every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 47/100: a Hold. The stock trades at $1.72 with a $45M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
SER’s broader alt-data profile also covers headcount (23 employees, according to LinkedIn), and sentiment (85/100). Every signal links to its own page with full history, the SER technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on SER is just below.
Serina Therapeutics AI Stock Analysis
Serina Therapeutics is a pharmaceutical company engaged in the development of therapeutic drugs for treating various medical conditions. Known for leveraging its proprietary polymer drug delivery technology, the company is focused on addressing unmet medical needs with innovative solutions.
Analysis generated October 1, 2026.
Recent Serina Therapeutics Stock Alerts
|
Serina Therapeutics | October 15 Price is up by 7% in the last 24h. |
|
Serina Therapeutics | October 14 Price is down by -6% in the last 24h. |
|
Serina Therapeutics | October 13 Price is down by -6.6% in the last 24h. |
|
Serina Therapeutics | October 5 Price is up by 7.1% in the last 24h. |
Serina Therapeutics Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 0 | N/A | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 23 | 0% | |
| Employee Recommend | 0 | N/A | |
| Business Outlook | 0 | N/A | |
| Sentiment | 85 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 3 | 85.0% | |
| Stocktwits Mentions | 2 | 33.3% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 0.8% |
About Serina Therapeutics (SER)
Serina Therapeutics Inc is an innovative biotechnology firm dedicated to addressing unmet medical needs in oncology and neurology through its proprietary polymer-based drug delivery platform. This advanced technology enhances the efficacy of therapies, significantly improving patient outcomes while positioning the company for sustainable growth in the competitive biopharmaceutical landscape. With a robust pipeline of product candidates and strategic collaborations, Serina is poised to transform healthcare solutions, underscoring its commitment to delivering value for investors and advancing therapeutic possibilities.
| Price | $1.72 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $45M |
| Year Range | $1 – $5 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Serina Therapeutics News
View more →
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology ConferenceJuly 24 - GlobeNewswire |
|
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s DiseaseJuly 23 - GlobeNewswire |
|
Serina Therapeutics Appoints Farrell Simon to its Board of DirectorsJuly 22 - GlobeNewswire |
|
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s DiseaseJuly 9 - GlobeNewswire |
|
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 ProgramJune 30 - GlobeNewswire |
See Serina Therapeutics’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for SER, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREESerina Therapeutics Earnings & Financial Performance
View all earnings →Serina Therapeutics Insider Trading Activity
View all →| Brannan Stephen K. filed to sell 1,000 shares at $0.0. Jul 7 '26 |
| WILSON KAREN J filed to sell 10,100 shares at $0.0. Jun 12 '26 |
| WILSON KAREN J filed to sell 5,100 shares at $0.0. Jun 11 '26 |
| Venkatesan Jay filed to sell 589 shares at $0.0. May 22 '26 |
| WILSON KAREN J filed to sell 20,000 shares at $0.0. May 22 '26 |
Serina Therapeutics Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Serina Therapeutics
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
INmune BioINMB |
$1.57 4.9% | $46M | 45 |
 |
Tevogen Bio HoldingsTVGN |
$7.07 0.1% | $46M | 40 |
 |
Aldeyra TherapeuticsALDX |
$0.70 5.1% | $48M | 60 |
 |
Hyperion DeFiHYPD |
$2.84 9.8% | $48M | 59 |
 |
Werewolf TherapeuticsHOWL |
$0.98 1.7% | $48M | 46 |
Explore Serina Therapeutics Data
Frequently Asked Questions: Serina Therapeutics (SER)
Serina Therapeutics has an AltIndex AI Score of 47/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
47/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Serina Therapeutics (SER) stock is $1.72 with a market cap of $45M.
As of today, Serina Therapeutics’s PE (Price to Earnings) ratio is —.
View the latest Serina Therapeutics insider transactions to see recent buying and selling activity by company executives and directors.
Check the Serina Therapeutics congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The SER stock price chart above shows Serina Therapeutics’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Serina Therapeutics technical analysis for RSI, moving averages, and more.
See the stocks similar to Serina Therapeutics section on this page for companies in the same industry ranked by market cap and AI Score.
